MedPath

KING HUSSEIN CANCER CENTER

🇯🇴Jordan
Ownership
-
Established
1997-01-01
Employees
-
Market Cap
-
Website
http://www.khcc.jo/

Real-World Study Affirms Ribociclib's Efficacy in HR+/HER2- Metastatic Breast Cancer

A retrospective study confirms that ribociclib combined with endocrine therapy is effective for HR+/HER2- metastatic breast cancer in real-world settings.

© Copyright 2025. All Rights Reserved by MedPath